- Abstract Number: 1852
Validating Patient Reported Outcomes in Older Veterans with Chronic Back Pain
- Abstract Number: 370
Validation of 2016 ACR/EULAR Classification Criteria of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis in Japanese Patients
- Abstract Number: 2950
Validation of a Definition for Flare in Patients with Established Gout
- Abstract Number: 1870
Validation of an Electronic Version of the Michigan Body Map
- Abstract Number: 2858
Validation of Biomarkers to Predict Flare in Polyarticular JIA upon Stopping Anti-TNF Therapy
- Abstract Number: 2631
Validation of Clinically Relevant Improvement in Children and Adolescents with cSLE
- Abstract Number: 2958
Validation of Flare Criteria for Children and Adolescents with Systemic Lupus Erythematosus
- Abstract Number: 1494
Validation of New Criteria in “The Guidance for Diagnosis of Sjögren’s Syndrome in Pediatric Patients”
- Abstract Number: 2548
Validation of New Potential Targets for Remission and Low Disease Activity in Psoriatic Arthritis in Patients Treated with Golimumab
- Abstract Number: 248
Validation of Objective Quantification System for Disease Progression in Patients with Juvenile Idiopathic Arthritis
- Abstract Number: 586
Validation of Online Calibration Modules for the Spondyloarthritis Research Consortium of Canada MRI Scores Based on Real-Time Experiential Learning
- Abstract Number: 1604
Validation of Remission and Lupus Low Disease Activity State As Predictors of Organ Damage in SLE
- Abstract Number: 1508
Validation of Self-Reported Inflammatory Back Pain Score Compared to Rheumatology Consultation in University Students
- Abstract Number: 1765
Validation of the ACR EULAR Provisional 2017 Classification Criteria of Granulomatosis with Polyangiitis (GPA) Amongst Patients with ANCA Associated Vasculitis
- Abstract Number: 1360
Validation of the Health Assessment Questionnaire-Upper Extremity (HAQUP) in Patients with Rheumatoid Arthritis
- Abstract Number: 94
Validity Evidence for an Objective Structured Clinical Examination Station to Assess Knee Arthrocentesis Skill
- Abstract Number: 2039
Validity of the Wpai-SHP in Psoriatic Arthritis and Estimation of the Minimally Important Difference
- Abstract Number: 464
Value of Matrix Metalloproteinase-3 Regarding Prediction for Joint Destruction at 1 Year Is Different between Sexes in Patients with Rheumatoid Arthritis
- Abstract Number: 701
Variability in ICAP (International Consensus on ANA Patterns) Pattern Reporting in Testing for Antinuclear Antibodies (ANA) By Indirect Immunofluorescence Assay (IFA)
- Abstract Number: 700
Variability in Method of Testing for Antinuclear Antibodies (ANA): A Survey of Participants in the College of American Pathologist’s (CAP) Proficiency Testing Program
- Abstract Number: 1058
Variation in DMARD Therapy Following Methotrexate Failure for Newly-Identified Rheumatoid Arthritis in a National Veterans Health Administration Cohort
- Abstract Number: 929
Variation in SLE-Related Pain – a Seven Year Follow-up Study
- Abstract Number: 472
Viral Hepatitis Influences Patient Reported Outcomes Measures in Rheumatoid Arthritis
- Abstract Number: 2692
Vitamin D Deficiency in Systemic Sclerosis Patients: Relations with Multiple Clinical Parameters and Standard Treatment
- Abstract Number: 666
Vitamin D Deficiency Is Associated with Increased Serum Cholesterol Among Patients with Systemic Lupus Erythematosus
- Abstract Number: 1739
Vδ1, Vδ2, and Other γδT Cells in Blood and Synovium of Rheumatoid Arthritis and Other Autoimmune Arthritides
2017 ACR/ARHP Annual Meeting
November 3-8, 2017 in San Diego, CA